In this June edition of the Journal of Drugs in Dermatology (JDD), we’re excited to showcase a selection of groundbreaking research and expert insights that delve into the latest advancements and treatments in dermatology. From innovative acne scar therapies to in-depth analyses of topical acne treatments, this month’s featured articles provide a comprehensive overview of current dermatological trends and discoveries. Straight from the Editor’s desk, we share this month’s issue highlights.
Consensus Statements on the Use of Novel Formulations of Isotretinoin: A Modified Delphi Process comments on the recent advancements in isotretinoin formulations and considerations to be taken regarding their differences.
Hypothalamic-Pituitary-Adrenal Axis Response in Patients With Acne Vulgaris Treated With Clascoterone evaluates two open-label, multicenter, Phase 2 trials of HPA axis suppression in patients with moderate-to-severe acne vulgaris.
Investigating the Relationship Between Acne and Vasodilatory Medications in a Hospital-Wide Adult Population shares the results of a retrospective cohort study designed to determine the correlation between vasodilator usage and the risk of developing acne.
Treatment of Acne Scars with Microneedling and Chemical Reconstruction of Scarred Skin Therapy (CROSS) Using Penol/Croton Oil Combination assesses and reports on the results of patients treated over a 5-year period.
Sunscreen Practices and Preferences of Skin of Color Patients highlights the differences in motivations, sunscreen preferences, sources of information, and knowledge levels about sun protection between non-White Hispanic and SOC individuals.
Find more JDD Issue Highlights here.
